Consolidated Statements of Cash Flow | |
Cash and cash equivalents, beginning of period | 465.56M |
Cash Flows From Operating Activities: | |
Net income | 198.46M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
(Gains) losses on investments | 88K |
Amortization of investments | |
Equity in net income of affiliates | -7.96M |
Dividends received from affiliates | 8.62M |
Amortization of debt issuance costs | |
Deferred income taxes | 15.92M |
Stock-based compensation | 54.28M |
Depreciation and other amortization | |
Amortization of deferred sales commissions | 11.87M |
Payment of capitalized sales commissions | |
Contingent deferred sales charges received | |
Proceeds from the sale of trading investments | |
Purchase of trading investments | |
Consolidated collateralized loan obligation entity operating activities: | |
(Gains) losses | -8.09M |
Amortization of investments | -456K |
Net decrease in other assets and liabilities, including cash | 74.36M |
Changes in other assets and liabilities: | |
Investment advisory fees and other receivables | 5.37M |
Other assets | 13.24M |
Accrued compensation | -50.66M |
Accounts payable and accrued expenses | 2.33M |
Taxes payable | |
Other liabilities | 4.89M |
Net cash provided by operating activities | |
Cash Flows From Investing Activities: | |
Additions to equipment and leasehold improvements | -8.79M |
Net cash paid for intellectual property acquired | -25K |
Payments received on note receivable from affiliate | |
Proceeds from the sale of available-for-sale investments and investments in affiliates | 8.97M |
Purchase of available-for-sale investments and investments in affiliates | -17.14M |
Consolidated collateralized loan obligation entity investing activities: | |
Proceeds from sales and maturities of investments | 126.18M |
Purchase of investments | -203.05M |
Net cash provided by investing activities | -108.98M |
Cash Flows From Financing Activities: | |
Distributions to non-controlling interest holders | |
Excess tax benefit of stock option exercises | 3.71M |
Proceeds from issuance of Non-Voting Common Stock | 53.75M |
Repurchase of Non-Voting Common Stock | -205.03M |
Principal repayments on notes receivable from stock option exercises | 2.34M |
Dividends paid | -89.57M |
Proceeds from the issuance of mutual fund subsidiaries' capital stock | |
Redemption of mutual fund subsidiaries capital stock | |
Net cash provided by (used for) financing activities | -252.99M |
Effect of currency rate changes on cash and cash equivalents | -1.94M |
Net increase in cash and cash equivalents | -87.4M |
Cash and cash equivalents, end of period | 378.16M |
Supplemental Cash Flow Information: | |
Cash paid for interest | 20.19M |
Cash paid for interest by consolidated collateralized loan obligation entity | 6.75M |
Cash paid for income taxes | 81.77M |
Supplemental Schedule of Non-Cash Operating Transactions: | |
Increase in other assets, net of other liabilities, due to consolidation of collateralized loan obligation entity | |
Supplemental Schedule of Non-Cash Investing Transactions: | |
Decrease in investments due to net deconsolidations of sponsored investment funds | -21.32M |
Decrease in non-controlling interests due to net deconsolidations of sponsored investment funds | -1.57M |
Increase in fixed assets due to non-cash fixed asset additions | 84K |
Increase in investments due to consolidation of collateralized loan obligation entity | |
Supplemental Schedule of Non-Cash Financing Transactions: | |
Exercise of stock options through issuance of notes receivable | 870K |
Increase in borrowings due to consolidation of collateralized loan obligation entity |